Successfully Producing Insoluble Proteins Using Inclusion Bodies

Source: Lonza

Despite the historically bad reputation of inclusion bodies (IBs), they can often present a more economical option from a bioprocessing perspective. Knowing how to use them effectively and efficiently, though, requires extensive experience with microbial processes using advanced engineering and process development capabilities.

Lonza Pharma & Biotech’s Jonas Mueller, team manager, and Nikolay Krumov, senior project leader, recently hosted the webinar Inclusion Bodies ― Mother Nature’s Help or Hindrance? In it, the pair discussed the pros and cons of soluble and insoluble processes, shared their experiences with isolating, solubilizing, and properly re-folding, and argued that the right approach to insoluble processes can not only be viable at scale but also can offer great opportunities to improve the total process outcome versus soluble production. They also reviewed strategies and future innovation to improve the performance of Lonza’s IB processes.

Download the full article to review the Q&A session held after the event, where the presenters addressed attendee questions about the details of the presentation.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online